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Abstract 
Tri- and dipeptide are transported in the kidney by PEPT1 and PEPT2 isoforms. The aim of 
this study was to investigate differences in transport kinetics between renal brush border 
(BBMV) and outer medulla (OMMV) membrane vesicles (where PEPT1 and PEPT2 are 
sequentially available) for a range of di- and tripeptides and peptidomimetic drugs. This was 
accomplished through the use of the potential sensitive fluorescent dye 3,3’-
dipropylthiacarbocyanine iodide [DiS-C3-(3)]. BBMV and OMMV were prepared from rat 
kidney using standard techniques. The presence of PEPT1 in BBMV and PEPT2 in OMMV 
was confirmed using Western blotting. Fluorescence changes were measured when extra-
vesicular media at pH 6.6 containing 0-1 mM substrates was added to a cuvette containing 
vesicles pre-equilibrated at pH 7.4 and 2.71M DiS-C3-(3). An increase in fluorescence 
intensity occurred upon substrate addition reflecting the expected positive change in 
membrane potential difference. Of the range of substrates studied, OMMV manifested the 
highest affinity to cefadroxil and Valacyclovir (Km 4.3 ± 1.2 and 11.7 ± 3.2µM respectively) 
compared to other substrates, whilst the BBMV showed a higher affinity to Gly-His (Km 15.4 
± 3.1µM) compared to other substrates. In addition, OMMV showed higher affinity and 
capacity to Gly-Gln (Km 47.1 ± 9.8µM, 55.5 ± 2.8 F/S/mg protein) than BBMV (Km 78.1 ± 
13.3µM and 35.5 ± 1.7 F/S/mg protein respectively). In conclusion, this study successfully 
separated the expression of PEPT1 and PEPT2 into different vesicle preparations inferring 
their activity in different regions of the renal proximal tubule.  
Key Words: DiS-C3-(3); PEPT co-transporters; renal membrane vesicles. 
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Introduction 
The generation and regulation of a membrane potential difference is a dynamic process and 
fundamentally crucial to many physiological functions. For example, the energy released 
from ATP hydrolysis is used by the Na+, K+ ATPase to transport three Na+ ions out of the cell 
in exchange for two K+ ions pumped into the cell (Blostein 1999). This, in combination with 
the passive potassium and chloride fluxes creates a negative membrane potential difference 
that favours the entry of sodium ions. This electrochemical gradient generates the driving 
force that facilitates the efficient absorption of many nutrients and some important drugs 
(Faller 2008; Jorgensen 1986). The reabsorption of amino acids in the kidney proximal tubule 
is a vital process to the body’s protein balance. Small peptides in the form of 2-3 amino acids 
are transported by the H+-dependent transporters PEPT1 (low-affinity/high-capacity) and 
PEPT2 (high-affinity/low-capacity) (Daniel and Kottra 2004). The translocation of di- and 
tripeptides by these cotransporters is forced by a transmembrane electrochemical proton 
gradient. This is mainly facilitated by the apical Na+-H+ exchanger (NHE3), which acidifies 
the lumen to around pH 6.7-6.8 by continuously secreting H+ across the brush border 
membrane (Daniel and Kottra 2004; Vieira and Malnic 1968). The resultant H+ inward 
electrochemical gradient can then be utilised by PEPT cotransporters to force the uptake of 
any of the naturally-occurring 400 dipeptide and 8000 potential tripeptide combinations into 
the proximal tubule cells (Anderson et al. 2010; Rubio-Aliaga 2008). PEPT transporters are 
also capable of transporting a vast range of peptidomimetic drugs including β-lactam 
antibiotics of the aminocephalosporin (e.g. cefadroxil) and Penicillin (e.g. ampicillin) classes; 
some antiviral (e.g. valacyclovir); and anti-tumour drugs (e.g. δ-amino-levulinic acid and γ-
glutamyl-L-cysteine); and selected angiotensin converting enzyme (ACE) inhibitors (e.g. 
captopril) (Brandsch et al. 2008).  
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PEPT1 and PEPT2 transporters are heterogeneously distributed in the renal proximal tubule, 
as PEPT1 is confined to segment 1, while PEPT2 is restricted predominantly to the later S3 
segments (Shen et al 1999). PEPT2 was found in higher quantity than PEPT1 (Leibach and 
Ganapathy 1996; Smith et al 1998), hence it was suggested that PEPT2 is the main 
cotransporter for the uptake of peptides and peptidomimetic drugs (Shen et al. 1999). Several 
studies using either transfected cell lines with PEPT1 and PEPT2 (Terada et al 1997) or 
BBMV (Ries et al 1994; Takahashi et al 1998) revealed that β-lactam antibiotic containing an 
α-amino group (e.g cefadroxil) had much higher affinity to the renal PEPT2. However, the 
relative contribution of the native PEPT1 and PEPT2 isoforms in transporting oligopeptides 
and peptidomimetic drugs in the renal proximal tubule is not clear yet. It was suggested that 
further studies investigating the distribution and expression level of PEPT1 and PEPT2 and 
also their contribution to the tubular reabsorption are needed for differentiating between their 
roles (Takahashi et al 1998).   
 
In the past BBMV have been a popular method for studying the characteristics of di- and 
tripeptide transport by PEPT1 and PEPT2 (Daniel et al 1991; Ries et al 1994; Takahasi et al 
1998). This is partly because the absence of metabolic machinery allows the accumulation of 
the intact substrate in the intra-vesicular space to be measured. Traditionally, such 
experiments have involved the measurement of radioisotope flux (Daniel et al 1991; Ries et 
al 1994; Takahasi et al 1998) or DiS-C3-(5) (Plášek et al 1994). We have developed a method 
of measuring the kinetic parameters for the uptake of some di- and tripeptide and selected 
peptidomimetic drugs into renal BBMV and OMMV via the use of the fluorescent potential 
sensitive dye, 3,3’-dipropylthiacarbocyanine iodide [DiS-C3-(3)]. In a previous publication 
we showed that DiS-C3-(3) could be used to detect changes in membrane potential difference 
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in renal membrane vesicles but did not measure the kinetics of substrate transport (Alghamdi 
and King 2012). The reason why it is important to measure the transport kinetics in different 
regions of the kidney is predicting the bioavailability of different substrates and drugs or 
where genetic variations exist in the transporters and their expression.   
 
Materials and Methods 
Chemicals and Kidneys 
All chemicals and reagents used in this study were obtained from SIGMA, Chem-Supply 
AppliChem, Santa Cruz Biotechnology, or GE Healthcare and were of analytical quality. 
Kidneys were obtained from male Wistar rats of 6-7 months old, which were sacrificed by 
stunning and cervical dislocation. The kidneys were snap frozen in liquid nitrogen and then 
transferred to a -80°C freezer until used for the preparation of BBMV and OMMV. This 
study was approved by the Animal Ethics committee of the University of New England, and 
complies with the Guide for the care and use of laboratory Animals published by the US 
National Institute of Health (NIH Publication No. 85-23, revised 1996). 
 
Isolation of BBMV and OMMV and quality control 
The BBMV and OMMV were isolated by the two-step Mg++ /EGTA precipitation method 
(Biber et al 1981; Brown et al 1993; Daniel et al 1991). BBMV were prepared from ~0.5-1 
mm thick slices of superficial cortex, while OMMV were prepared from slices of outer 
medulla, which are characterised by having red stripes (Kragh-Hansen and Shiekh 1984; 
Smith et al 1998). The integrity of the purified vesicles was examined using marker enzyme 
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assays. The enrichments of alkaline phosphatase and leucine aminopeptidase for BBMV were 
13.51 ± 2.07 and 12.82 ± 1.32 fold respectively, and for OMMV were 11.3 ± 0.75 and 17.23 
± 2.4 fold respectively. These values of enzyme enrichments indicate good, non-
contaminated vesicles (Biber et al 1981). Protein concentration was quantified using 
Bradford’s method (Brown et al 1993).  
 
After isolating the vesicles and before placing them in the -80°C freezer, they were suspended 
in buffer 1 (intra-vesicular medium) containing (in mM): 100 mannitol, 100 KH2PO4 and 10 
HEPES (pH 7.4 with TRIS) and centrifuged at 31,000 x g for 20 min at 4°C (Daniel et al 
1991). The supernatant was discarded and the pellet was re-suspended with the same solution 
and pre-equilibrated using freeze-thaw fractionation (Donowitz et al 1987). The transport 
buffer (buffer 2) (extra-vesicular medium) contained (in mM): 100 mannitol, 100 KH2PO4, 
and 10 2-(N-Morpholino) ethanesulfonic acid (MES, pH 6.6 with TRIS).    
 
Western blot analysis   
As PEPT1 and PEPT2 are located in different segments of the kidney (superficial cortex and 
outer medulla, respectively) (Shen et al 1999), Western blot was used to confirm the 
positive/negative expression in the isolated BBMV and OMMV. BBMV and OMMV 
containing 45µg protein/sample were mixed in eppendorf tubes with the loading buffer (3X) 
containing 6% Sodium dodecyl sulfate (SDS), 0.3 % Bromophenol blue, 30% glycerol, 5% β-
mercaptoethanol, and 150 mM Tris-HCl (pH 6.8). They were transferred into a boiling water 
bath at 100°C for 5 minutes. After that, the tube contents were loaded onto Mini-Protean Bio-
Rad Gels 4-20 % and the first well was always loaded with 5 µl  of Precision Plus Protein 
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Standards as a molecular weight control ladder. Gels were run at 120 V constant voltage for 
40-90 minutes. The gels were then blotted with nitrocellulose membrane (semi-dry system) at 
120 mA for 3 hours. The membranes were stripped for 15 minutes as described by Kaur, 
Bachhawat (2009) and incubated overnight with blocking buffer 5 % skim milk dissolved in 
TBS-T buffer containing (in mM) 150 NaCl, 20 Tris-HCl (pH 7.5) and 0.1 % Tween 20. The 
membranes were then incubated with either mouse monoclonal anti-PEPT1 for 1 h at room 
temperature (RT) or with goat polyclonal anti-PEPT2 overnight at 4°C. This was followed by 
an hour’s incubation with HRP-conjugated goat anti-mouse and mouse anti-goat IgG 
respectively at RT. Between probing with the primary, and secondary antibodies and after 
incubation with the secondary antibodies, the membranes were washed 3 times for 10 min 
with TBS-T buffer. Protein bands were detected using ECLTM Western Blotting Analysis 
System (GE Healthcare) according to the manufacturer’s instructions. Scanned pictures of 
Hyperfilm ECL were taken using BIO-RAD GEL DOC EQ system. The membranes were 
transferred to a stripping buffer containing (in mM) 100 β-mercaptoethanol, 62.5 Tris-HCl 
(pH, 6.7), and 2% SDS at 55 C for 30 minutes, followed by 2 ×10 minute washes with TBS-
T. Then, they were incubated with the blocking buffer and reprobed with anti-β-Actin (mouse 
monoclonal) antibodies, following the steps described above. This was used as a loading 
control and confirmed that each lane had equal amounts of protein loaded into it (results not 
shown).  
 
Fluorescence Measurements of Substrate Transport 
These measurements were carried out at (20-24°C) in a fluorescence spectrophotometer 
(Perkin-Elmer LS 55), pre-set with: 5nm slit width, excitation and emission wavelengths of 
557 and 575nm respectively; and the cuvettes used had a pathlength of 2mm. Fluorescence 
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intensity (in arbitrary units) was recorded at 0.02 second intervals for about 80 seconds and 
displayed on a digital screen as a plot of fluorescence versus time (see Figure 2 for an 
example). 
 
Experiments were started by mixing appropriate volumes of buffer 2, 4µl from a 541µM 
stock (2.71µM final concentration) DiS-C3-(3), and sufficient vesicles to obtain a constant 
protein concentration of 45µg (maintaining a dye to protein ratio of 19.4µg/mg (Cassano et al 
1988; Wright et al 1981) to a total volume of 800µl into an Eppendorf tube. This Eppendorf 
tube was gently mixed using a pipette. The total volume was then divided into two matched 
cuvettes (each one had 396µl), one was for the sample, whilst the other one served as control. 
Both of which were placed into the fluorimeter and the fluorescence followed for 50 seconds 
to enable stabilisation of the signal. A series of concentrations of the substrates were made as 
stock solutions so that a constant volume of 4µl were added for each sample, as the addition 
of different volumes could cause variations in the fluorescence intensity. After adding 
substrates (e.g. Gly-Gln), the fluorescence was measured for approximately another 50 
seconds until the fluorescence had stabilised. Graphs of the fluorescence measured (in 
arbitrary units) vs. time (in 0.02s) were plotted as shown in Figure 2. In the control samples 
no substrates were added.   
 
Data Analysis and Presentation: 
The readings for the first period during which fluorescence was stable (approx. 50 seconds) 
were removed from all samples, as this period was used to check that the system was in the 
steady state. After that, all data were normalised and each sample was corrected for the 
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changes of fluorescence due to the addition of the substrate by subtracting the trace obtained 
for the corresponding control samples. Then, the average of these corrected readings for each 
concentration was plotted. The total change in fluorescence intensity was then calculated by 
subtracting the intensity at the start of the transport to the intensity at the plateau. This was 
then repeated for different substrate concentrations. The readings were then plotted against 
their corresponding substrate concentrations and fitted using a Michaelis-Menten curve (R2 
values which demonstrated a goodness of fit >90) and equation (𝑉 =
𝑉𝑚𝑎𝑥 [𝑆]
𝐾𝑚+[𝑆]
), which was 
then used to calculate Vmax and Km. Vmax values were calculated as F/0.02s/45µg protein, 
which were converted to F/s/mg protein. Student’s t-Test was then calculated using these 
equations: 𝑡 =  
𝐷𝑖𝑓𝑓𝑒𝑟𝑒𝑛𝑐𝑒 𝑏𝑒𝑡𝑤𝑒𝑒𝑛 𝑡ℎ𝑒 𝑡𝑤𝑜 𝑚𝑒𝑎𝑛𝑠
𝑠.𝑒.𝑜𝑓 𝑡ℎ𝑒 𝑑𝑖𝑓𝑓𝑒𝑟𝑒𝑛𝑐𝑒 
  and  𝑠. 𝑒. 𝑑𝑖𝑓𝑓𝑒𝑟𝑒𝑛𝑐𝑒 = √
𝐴𝑆
2
𝑛𝐴
+
𝐵𝑆
2
𝑛𝐵
 to 
illustrate significant differences between kinetic values. All of the results presented are means 
± SE of n = 6-8 samples. P values < 0.05 were considered to be statistically significant. 
Results 
Confirmation of the sequential distribution of PEPT1 and PEPT2 in BBMV and 
OMMV respectively 
All vesicles used in this study were examined by Western blot to confirm the correct 
distribution of PEPT1 and PEPT2. PEPT1, PEPT2 and β-actin protein bands were detected in 
BBMV and OMMV with molecular weight of 75, 85 and 43 kDa, respectively. As shown in 
the upper panel of Figure 1, PEPT1 was present in the first 2 lanes, which were loaded with 
BBMV, while it was absent in lanes 3-11 where OMMV were loaded. The middle panel of 
Figure 1 shows that PEPT2 was absent in lanes 4-6 and 8-11 in which BBMV were loaded, 
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while PEPT2 bands were clearly shown in the lanes loaded with OMMV. The bottom panel 
of Figure 1 shows that the house-keeper, ß-actin was present in all samples. 
 
Measurement of fluorescence changes as a function of time upon the addition of extra-
vesicular medium with or without 1000µM Gly-Gln 
Figure 2 shows the result of a single experiment representative of 7 such experiments for 
renal BBMV and OMMV. A sharp decrease in fluorescence was seen as soon as 1000µM 
Gly-Gln was added, followed by an increase and plateau with a largely unchanging 
fluorescence level that continued for the rest of the experiment. This general pattern was 
observed in all experiments when different concentrations of substrates were delivered to 
both BBMV and OMMV. When the same volume of extra-vesicular buffer containing no 
Gly-Gln was added to both BBMV and OMMV, there was a similar decrease in fluorescence 
followed by a plateau (Figure 2). This pattern of fluorescence was seen in all vesicles, except 
for at a low concentration of some substrates (10-50 µM) delivered to OMMV which showed 
a slightly smaller decrease in fluorescence than the control, followed by a sharp increase in 
fluorescence.  
 
Kinetics of substrate uptake into BBMV and OMMV  
Figures 3 to 5 compare the Michaelis-Menten curves for the transport kinetics of a range of 
substrates measured using an extra-vesicular pH of 6.6. When comparing the transport of 
Gly-Gln (circles, dashed line), Gly-His (squares, continuous line) and cefadroxil (triangles, 
bold dashed line) in BBMV (Figure 3), the Vmax for Gly-His transport was significantly 
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higher than for Gly-Gln transport (57.3 ± 2.1 F/s/mg protein and 35.5 ± 1.7 F/s/mg protein 
respectively, P= 0.001). Similarly, the Km for Gly-His transport was significantly lower than 
for Gly-Gln (15.4 ± 3.1M and 78.1 ± 13.3M respectively, P=0.002). cefadroxil (Figure 3) 
had an affinity for the transporters situated between Gly-His and Gly-Gln (34.1 ± 8.4M) but 
with a much higher capacity (82.7 ± 5.67 F/s/mg protein) than for the 2 dipeptides.  
 
The same trend for the two dipeptides’ transport was observed in OMMV (Figure 4) 
compared to BBMV, with a Km significantly lower for Gly-His (squares, continuous line) 
transport than Gly-Gln (circles, dashed line) (12.5 ± 3.1M and 47.1 ± 9.8M respectively, 
P=0.012) and a decrease (although not significant) in Vmax between Gly-His and Gly-Gln 
(61.1 ± 2.5 F/s/mg protein and 55.5 ± 2.8 F/s/mg protein respectively, P=0.1). However, 
and unlike the BBMV, cefadroxil had a significantly higher transporter affinity (4.3 ± 1.2M) 
than both dipeptides (squares, continuous line; Figure 4). In addition, the Km for Gly-Gly-His 
transport (triangles, dashed line) (47.5 ± 6.65M) was significantly lower than for Gly-His 
transport (P=0.002) but similar to the Gly-Gln transport. However, the Vmax for Gly-Gly-His 
transport (75.9 ± 2.33 F/s/mg protein) was significantly higher than for Gly-His (P=0.0034) 
and Gly-Gln (P=0.0006) transport. 
 
When comparing peptidomimetic drug substrates in OMMV, the Km of cefadroxil was 
significantly lower than δ-amino-levulinic (P=0.001), but close to statistical significance with 
Valacyclovir (P=0.06; Figure 5). Also, the Vmax was significantly higher for cefadroxil than 
for other two drugs (P=0.002 and 0.001 respectively, Table 1).         
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A complete list of the Km and Vmax for all substrates measured in the BBMV and OMMV is 
shown in table 1. This shows that the Vmax for Gly-Gln transport in BBMV was significantly 
lower than the Vmax for Gly-Gln (P=0.001) transport in OMMV. Also, the transport of Gly-
Gln in OMMV has a higher affinity than in BBMV, although not significant (P=0.09). 
However, while the same trends were observed for Vmax and Km
 in the case of Gly-His, the 
differences between BBMV and OMMV were not significant. In addition, there was no 
significant difference in the Vmax for cefadroxil transport between BBMV and OMMV, 
However the Km for cefadroxil transport in OMMV was significantly lower than in BBMV 
(P= 0.001). 
 
Discussion 
The reabsorption of important nutrients in the kidney occurs mostly in the proximal tubule 
where the proton-dependent PEPT1 and PEPT2 cotransporters are located. The 
electrochemical gradient created by the inward cation and membrane potential difference is 
the main force driving these reabsorptive processes. Indeed, the transport of these substrates 
by PEPT1 and PEPT2 is well defined to be a proton-dependent process in which translocation 
of the substrate is accompanied by hydrogen ion. Measuring the membrane potential 
difference could provide important insights to the renal functions for nutrient handling, 
wastes, and also the pharmacokinetics of many drugs. Several studies have shown the 
possible applications of Cyanine dyes as a membrane fluorescent biosensor on BBMV (Beck 
et al 1978; Cassano et al 1988; Kragh-Hansen et al 1982; Ries et al 1994; Vayro and 
Simmons 1996; Wright et al 1981). Some studies used extracellular pH 6.5-6.8 (Daniel et al 
1991; Kottra et al 2013) similar to the physiological level to create an inward H+ gradient for 
activating theses transporters. By following these studies, the H+ gradient was created by 
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adjusting the pH of the extra-vesicular and intra-vesicular medium to be 6.6 and 7.4 
respectively (~ 6.7 across the membrane). This is based on the hypothesis that at these pH 
environments and with increasing concentration of substrates delivered to either BBMV or 
OMMV, corresponding increases in the fluorescence signal (positive membrane potential 
difference) would result from a greater influx of protons, which would reflect the 
translocation of the substrates (Figures 2 to 5). These changes in fluorescence are similar to 
that seen in the study conducted by Ries et al. (1994), however they used a different 
membrane potential sensitive dye DiS-C3-(5), and they did not isolate different regions of the 
proximal tubule representing PEPT1 and PEPT2 (BBMV and OMMV respectively). 
Therefore, this prompted us to develop a method for measuring the membrane potential 
difference by DiS-C3-(3) while transporting substrates across BBMV and OMMV.  
 
In this study, the potential application of DiS-C3-(3) dye as a biosensor for the membrane 
potential difference in BBMV and OMMV was validated using the following experiments: 
(1) investigating the addition of the extra-vesicular medium (pH 6.6, without substrate), 
which resulted in an instantaneous decrease in fluorescence intensity followed by a steady 
plateau (Figure 2). This initial change in intensity is likely due to the perturbation of the 
sample by the addition of the medium (Ries et al 1994), as when larger volumes were added a 
larger negative deflection was observed (results not shown). The following plateau indicates 
that there were no changes in the membrane potential and hence that no transport happened 
across the membrane for the control samples (Figure 2). (2) investigating the addition of the 
extra-vesicular medium (pH 6.6) containing Gly-Gln to the same vesicles, which resulted in 
the same decrease as the control ones, but followed by an increase in the fluorescence signal 
which then reached plateau. This increase in the fluorescence intensity indicated 
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depolarisation of the membrane potential, which is most likely due to the translocation of the 
substrates with H+ across the membrane (Figure 2) (Ries et al 1994).   
 
Chen et al. (1999) demonstrated that although PEPT1 and PEPT2 showed high sequence 
homology (approx. 50%), there were considerable differences in terms of substrates affinity, 
stoichiometry, and effects of depolarization and hyperpolarization. They demonstrated that 
PEPT2 can be inactivated by either increasing the pH or by hyperpolarization. Another study 
conducted by Daniel et al. (1991) used similar vesicle preparations isolated from the brush 
border membrane of the kidney and investigated the transport of just two concentrations of 
Gly-Gln 0.1 μM and 1mM as a function of pH gradients. They showed that Gly-Gln transport 
depends on the presence of a transmembrane pH gradient, although the high affinity 
transporter PEPT2 was significantly more sensitive to pH than the low affinity transporter 
PEPT1. In this study, BBMV and OMMV respresent S1 and S3 of the proximal tubule 
respectively (where PEPT1 and PEPT2 are respectively located), and this heterogeneous 
distribution of these transporters was confirmed by Western blot (Figure 1) (Shen et al 1999). 
At pH 6.6, both BBMV and OMMV demonstrated a change in membrane potential 
difference, which is likely to be due to the transport of the substrate across the membrane. 
The physiological pH level in S3 was measured to be 6.7-6.8 ((Vieira and Malnic 1968), 
where NHE3 is highly active to acidify the lumen (Daniel and Kottra 2004), so the nature of 
these transporters requires such environment. This can also give valuable insights regarding 
the differences between two important regions of the kidney in terms of small peptide 
handling and pharmokinetics at different pH.  
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In our experiments, different concentrations of small peptides containing 2-3 amino acids and 
selected peptidomimetic drugs were delivered to BBMV and OMMV pre-equilibrated with 
the extra-vesicular buffer and DiS-C3-(3) dye at pH 6.6. This aimed to investigate the kinetic 
transport parameters (Km and Vmax) in two important regions of the renal proximal tubule (S1 
and S2) using DiS-C3-(3) dye. When the buffer (pH 6.6) containing the substrates was added 
to the vesicles (BBMV or OMMV) pre-equilibrated with DiS-C3-(3) dye and the signal 
corrected for the addition of buffer (control), the fluorescence intensity increased indicating 
depolarisation change of the membrane potential, which is therefore most likely due to the 
translocation of the substrates with H+ across the membrane (Figures from 3 to 5).    
 
PEPT1 and PEPT2 cotransporters are heterogeneously distributed in rat kidney, suggesting a 
sequential process in the flux of peptides and peptide-like drugs in the proximal tubule of the 
nephron, initially by a low affinity / high capacity co-transporter, followed by a high affinity / 
low capacity co-transporter respectively. Since PEPT2 was found in larger abundance than 
PEPT1 in kidney (Leibach and Ganapathy 1996; Smith et al 1998), it was expected that 
peptides and peptidomimetic drugs are predominately transported by PEPT2 (Shen et al 
1999). This assumption is supported by PEPT2 knockout mouse studies that showed PEPT2 
protein is responsible for transporting about 85% of dipeptides (Daniel and Rubio-Aliaga 
2003; Ocheltree et al 2005) and about 95% of cefadroxil (Shen et al 2007). In most cases, 
PEPT2 demonstrates higher affinity than PEPT1 in transporting peptidomimetic drugs such 
as β-lactam antibiotics, which contain an α-amino group and p-hydroxyphenyl group in their 
chemical configuration, at therapeutic concentrations (Inui et al 2000; Takahashi et al 1998). 
This is in agreement with our findings that OMMV (where PEPT2 is located) has a higher 
affinity for most substrates compared to BBMV (PEPT1), with cefadroxil having the highest 
affinity (table 1). This value is comparable and in a good correlation with previous studies 
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reporting that cefadroxil had a very high affinity for PEPT2 in the transfected cell line LLC-
PK1 (Terada et al 1997) and to the native PEPT2 in BBMV isolated from rat kidneys (Inui et 
al 2000; Ries et al 1994; Takahashi et al 1998) where the transported Km and Ki was around 3 
µM. Valacyclovir had the second highest affinity in OMMV (table 1), and to compare it with 
cefadroxil, the former contains α-amino group and p-hydroxyphenyl while the latter contains 
just an α-amino group. In contrast, δ-amino-levulinic acid, which does not contain these 
groups showed the lowest affinity in OMMV (Table 1). These results are in good agreement 
with the literature (Bransch et al 2008), confirming that these functional groups in the 
chemical structure can play an important role in the recognition of substrates by PEPT2. 
Also, it suggests that S3 is the predominant region for transporting these substrates at low 
therapeutic concentration, while competing with the hydrolysed small peptides in the kidney.  
 
On the other hand, in OMMV the transport of Gly-His (a positively charged dipeptide) 
demonstrated significantly higher afinnity than Gly-Gln (a neutral dipeptide) and Gly-Gly-
His (a tripeptide), but showed significantly higher capacity for Gly-Gly-His (table 1). 
Although, the transport of Gly-Gln by OMMV was significantly higher in affinity and 
capacity than BBMV, no significant changes in affinity or capacity were observed between 
BBMV and OMMV for Gly-His (table 1). This could be explained by the charge-to-peptide 
stoichiometry of PEPT1 for acidic and neutral peptides which is 1:1 and its preference for 
positively charged dipeptides (Bransch et al 2008; Steel et al 1997), while the proton-to-
substrate stoichiometry of PEPT2 for neutral peptides is 2:1 (Chen et al 1999). The 
extracellular pH plays a substantial role in increasing the affinity of both anionic and cationic 
compounds, such that decreasing the extracellular pH increases the affinity of anionic and 
neutral compounds, whereas increasing extracellular pH decreases the affinity of cationic 
ones (Amasheh et al 1997). It is clear that changing the pH and peptide charge can play a 
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substantial role in determining the transport by PEPT1 and PEPT2. Therefore, one 
explanation of the higher transport affinity and capacity of Gly-Gln (neutral dipeptide) by 
OMMV (table 1) is that the proton-to-substrate stoichiometry is 2:1, but also, that the 
positively charged dipeptide can increase the affinity and capacity of these transporters at 
physiological pH. 
 
In this study, we have measured the transport kinetics of neutral and positively charged small 
peptides and selected peptidomimetic drugs delivered to BBMV and OMMV by using the 
membrane potential difference sensitive dye DiS-C3-(3). This is the first report to infer the 
relative contribution of the S1 and S3 segments from the renal proximal tubule (which are 
represented by BBMV and OMMV containing PEPT1 and PEPT2 cotransporters 
respectively) to the tubular reabsorption of these substrates in the kidney. These findings 
could provide valuable insights regarding the transport efficiency between these different 
substrates and between PEPT1 and PEPT2 in handling nutrients and peptide-like drugs. This 
could be of importance when considering substrate or drug distribution in the body. 
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Figure and Table Legends 
Fig. 1 The presence of PEPT1 and PEPT2 in BBMV and OMMV, respectively, isolated from 
the kidneys of adult rats. The protein concentration loaded in each gel was constant 45µg. As 
labelled in the graph PEPT1 was present in BBMV, and PEPT2 was present in OMMV. 
 
Fig. 2 Changes in fluorescence intensity measured upon Gly-Gln (1000µM) addition to either 
BBMV or OMMV. Controls (no substrate addition) for these samples were run as indicated 
in this graph. The arrow indicates the point at which the Gly-Gln was added. Data shown are 
taken from a single experiment representative of 7 such experiments. 
 
Fig. 3 Change in fluorescence (F/0.02s, > 0) as a function of substrate concentration 
delivered to the BBMV at pH 6.6. Squares joined with a continuous line represent the values 
obtained for Gly-His. Circles joined with a dashed line represent the values obtained for Gly-
Gln. Triangles joined by a bold dashed line represent the values for Cefadroxil. Curves were 
fitted according to the Michaelis-Menten equation. Data shown are means ± SE, where n=8. 
 
Fig. 4 Change in fluorescence (F/0.02s, > 0) as a function of substrate concentration 
delivered to the OMMV at pH 6.6. Squares joined with a continuous line represent the values 
obtained for Gly-His. Circles joined with a dashed line represent the values obtained for Gly-
Gln. Triangles joined with a bold dashed line represent the values for Gly-Gly-His. Curves 
were fitted according to the Michaelis-Menten equation. Data shown are means ± SE, where 
n=8 
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 Fig. 5 Change in fluorescence (F/0.02s, > 0) as a function of substrate concentration 
delivered to the OMMV at pH 6.6. Squares joined with a continuous line represent the values 
obtained for Valacyclovir. Circles joined with a dashed line represent the values obtained for 
Cefadroxil. Triangles joined with a bold dashed line represent the values for δ-amino-
levulinic acid. Curves were fitted according to the Michaelis-Menten equation. Data shown 
are means ± SE, where n=6. 
 
Table 1. The Km (M) and Vmax (F/s/mg protein) kinetic parameters for different 
substrates in two regions of the kidney (BBMV and OMMV). The affinity and velocity 
values of these substrates are shown in order from the highest to the lowest. Data shown are 
means ± SE, where n=6-8. 
 
 
